COVID-19 Rapid Evidence Reviews Group (CORRE)
Bringing together evidence to tackle COVID-19
The COVID-19 Rapid Evidence Reviews Group (CORRE) is a collaborative effort between ISARIC and several other international partners that aims to provide high quality rapid evidence synthesis for use in COVID-19 research activities.
Reports produced by the COVID-19 Rapid Evidence Reviews Group seek to provide an answer to a list of relevant research questions. The final purpose is to accelerate our collective understanding of COVID-19 to help improve patient care and inform public health policy.
Clinical Characterisation of COVID-19: a systematic review (submitted)
Clinical Management Guidelines for COVID-19: a systematic review (ongoing)
Obesity An independent risk factor for COVID-19 severity
Scope, quality, and inclusivity of clinical guidelines produced early in the COVID-19 pandemic - rapid review
What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
Transmission dynamics and secondary attack rate of SARS-CoV-2
What is the duration and dynamics of viral shedding in various body fluids in coronaviruses
ISARIC associated clinical studies in COVID-19
Members of the COVID-19 Rapid Evidence Reviews Group include:
Institute of Social and Preventive Medicine (ISPM)
Liverpool Health Protection Research Unit (HPRU)
School of Health Sciences, City, University of London